{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:47:48Z","timestamp":1792640868914,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.atherosclerosis.2024.119100","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T16:49:07Z","timestamp":1734626947000},"page":"119100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Risk of atherosclerosis-related diseases in polymyositis and dermatomyositis patients: A large-scale population-based study"],"prefix":"10.1016","volume":"401","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5285-6244","authenticated-orcid":false,"given":"Lior","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niv","family":"Ben-Shabat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Gendelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassem","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Ehrenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uria","family":"Shani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonatan Shneor","family":"Patt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Karra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulla","family":"Watad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Amital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Dudkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2024.119100_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jbspin.2017.03.005","article-title":"Inflammatory myopathies: a new landscape","volume":"85","author":"Meyer","year":"2018","journal-title":"Joint Bone Spine"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2024.119100_bib2","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2019.100018","article-title":"Polymyositis and dermatomyositis \u2013 challenges in diagnosis and management","volume":"2","author":"Yang","year":"2019","journal-title":"J. Transl. Autoimmun"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/rheumatology\/keh404","article-title":"Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis","volume":"44","author":"Ponyi","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib6","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/rheumatology\/keh723","article-title":"Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis","volume":"44","author":"Kang","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4103\/0019-5154.100486","article-title":"Clinical presentation and evaluation of dermatomyositis","volume":"57","author":"Marvi","year":"2012","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/mus.24566","article-title":"An overview of polymyositis and dermatomyositis","volume":"51","author":"Findlay","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib9","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib10","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.jacc.2019.10.009","article-title":"The global burden of cardiovascular diseases and risk factors: 2020 and beyond","volume":"74","author":"Mensah","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib11","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1016\/j.jacc.2020.11.021","article-title":"The global burden of cardiovascular diseases and risks: a compass for global action","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib12","doi-asserted-by":"crossref","first-page":"E139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics\u20142020 update a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib13","doi-asserted-by":"crossref","first-page":"E93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics - 2023 update: a report from the American heart association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib14","doi-asserted-by":"crossref","first-page":"E67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics-2018 update: a report from the American heart association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib15","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1093\/eurheartj\/ehv220","article-title":"Cardiovascular diseases in populations: secular trends and contemporary challenges\u2014geoffrey Rose lecture, European Society of Cardiology meeting 2014","volume":"36","author":"Roger","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cjca.2021.02.009","article-title":"Cardiovascular risk factors and prevention: a perspective from developing countries","volume":"37","author":"Teo","year":"2021","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib17","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Collaboration","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib18","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/acr.22173","article-title":"Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies","volume":"66","author":"Yurkovich","year":"2014","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib19","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","author":"Avina-Zubieta","year":"2012","journal-title":"Ard.Bmj.Com."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.119100_bib20","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/annrheumdis-2012-202007","article-title":"The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study","volume":"72","author":"Man","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib21","article-title":"History of discovery inflammation in atherosclerosis inflammation: an enduring flame","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000291","article-title":"Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies","volume":"2","author":"Schwartz","year":"2016","journal-title":"RMD Open"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib23","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1093\/rheumatology\/keab851","article-title":"Cardiovascular events in adult polymyositis and dermatomyositis: a meta-analysis of observational studies","volume":"61","author":"Xiong","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib24","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1093\/eurheartj\/ehac516","article-title":"Association of anti-Ro seropositivity with cardiac rhythm and conduction disturbances","volume":"43","author":"Akuka","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib25","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(21)02249-2","article-title":"Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study","volume":"398","author":"Barda","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib26","series-title":"Familial Mediterranean Fever Association with Schizophrenia: Insights from Big Data Analysis","author":"Sharif","year":"2020"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14729","article-title":"Utilisation of healthcare services and drug consumption in fibromyalgia: a cross-sectional analysis of the Clalit Health Service database","volume":"75","author":"Gendelman","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.semarthrit.2014.03.004","article-title":"Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies","volume":"44","author":"Ungprasert","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib29","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3899\/jrheum.090061","article-title":"Arterial events in persons with dermatomyositis and polymyositis","volume":"36","author":"Tisseverasinghe","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib30","first-page":"461","article-title":"Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study","volume":"55","author":"Rai","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib31","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/heartjnl-2016-310894","article-title":"Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study","volume":"103","author":"Andell","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib32","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1160\/TH12-10-0768","article-title":"Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases","volume":"109","author":"Carbone","year":"2013","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib33","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.autrev.2012.03.002","article-title":"Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity. A critical updated review","volume":"11","author":"Artenjak","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib34","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-0036-1597286","article-title":"New insights in the pathophysiology of antiphospholipid syndrome","volume":"44","author":"Sacharidou","year":"2018","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib36","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib37","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/0961203309106832","article-title":"The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe","volume":"18","author":"Cervera","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib38","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1474-4422(09)70239-X","article-title":"Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study","volume":"8","author":"Urbanus","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib39","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1046\/j.1538-7836.2003.00261.x","article-title":"Inflammation and thrombosis","volume":"1","author":"Esmon","year":"2003","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib40","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1161\/01.ATV.0000166521.90532.44","article-title":"New links between inflammation and thrombosis","volume":"25","author":"Wagner","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib41","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.atherosclerosis.2020.07.027","article-title":"A link between inflammation and thrombosis in atherosclerotic cardiovascular diseases: clinical and therapeutic implications","volume":"309","author":"Oikonomou","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCRESAHA.117.310795","article-title":"Circulating platelets as mediators of immunity, inflammation, and thrombosis","volume":"122","author":"Koupenova","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00294","article-title":"Endothelial to mesenchymal transition represents a key link in the interaction between inflammation and endothelial dysfunction","volume":"9","author":"Cho","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib46","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2012.05.013","article-title":"Endothelial dysfunction in rheumatic autoimmune diseases","volume":"224","author":"Murdaca","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib47","doi-asserted-by":"crossref","first-page":"11324","DOI":"10.3390\/ijms150711324","article-title":"Endothelial dysfunction in chronic inflammatory diseases","volume":"15","author":"Steyers","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.106066","article-title":"Primary hypercholesterolemia and development of cardiovascular disorders: cellular and molecular mechanisms involved in low-grade systemic inflammation and endothelial dysfunction","volume":"139","author":"Collado","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib49","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2174\/1381612825666190430113212","article-title":"Accelerated atherosclerosis in rheumatoid arthritis: mechanisms and treatment","volume":"25","author":"Reiss","year":"2019","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaut.2007.02.004","article-title":"The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia","volume":"28","author":"Hahn","year":"2007","journal-title":"J. Autoimmun."},{"issue":"3 6","key":"10.1016\/j.atherosclerosis.2024.119100_bib51","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s40674-020-00152-z","article-title":"Cardiovascular risk in systemic sclerosis","volume":"6","author":"Angeloudi","year":"2020","journal-title":"Curr. Treatment Options Rheumatol."},{"issue":"2 2","key":"10.1016\/j.atherosclerosis.2024.119100_bib52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ncprheum0092","article-title":"Mechanisms of Disease: atherosclerosis in autoimmune diseases","volume":"2","author":"Sherer","year":"2006","journal-title":"Nat. Clin. Practice Rheumatology 2006"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib54","article-title":"Myocardial infarction, stroke, and psoriasis: a systematic review of observational studies","author":"Correa","year":"2022","journal-title":"Ann. Cardiol. Angeiol"},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib55","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13350","article-title":"Prevalence of and factors associated with primary medication non-adherence in chronic disease: a systematic review and meta-analysis","volume":"73","author":"Cheen","year":"2019","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.atherosclerosis.2024.119100_bib56","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/ajhp\/zxz284","article-title":"A systematic overview of systematic reviews evaluating medication adherence interventions","volume":"77","author":"Anderson","year":"2020","journal-title":"Am. J. Health Syst. Pharm."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024015314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024015314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T05:49:59Z","timestamp":1741844999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024015314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":56,"alternative-id":["S0021915024015314"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.119100","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of atherosclerosis-related diseases in polymyositis and dermatomyositis patients: A large-scale population-based study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.119100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119100"}}